Infectious Disease & Vaccines

Paper presents the first pre-clinical application of endogenous antibody recruitment to address multi-drug resistant Gram-negative infections

Explore how broadly neutralizing antibodies (bNAbs) are offering a new path to an HIV cure by targeting the latent HIV reservoir and preventing transmission.

Explore how the immune system battles mold in lungs. A new study reveals a key cytokine, GM-CSF, helps immune cells clear the dangerous fungal spores.

Collaboration to leverage Oxford Nanopore’s sequencing platform and Cepheid’s GeneXpert system to advance the field of sequencing for infectious diseases.

Researchers are developing new, portable breath analysis tools to diagnose tuberculosis and other diseases, making screenings more accessible in remote areas and beyond.

A new antifungal drug, mandimycin, tackles resistant fungal strains with a never-before-seen mechanism that avoids kidney toxicity.

Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.

Scientists probed how tick proteins influenced host immunity, paving the way for mRNA vaccines to block Lyme and other tick-borne diseases.

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.

Vaxart’s orally administered vaccine tablet was safe and elicited mucosal immunity in older adults.

Innovations like ClinFAST™ are streamlining the fill/finish process, reducing timelines while maintaining high-quality standards for clinical materials.

Virus-inspired delivery methods enable gene editing of dysregulated microbes.